Drug Development

Jun 01, 2018
By Pharmaceutical Technology Editors
Lonza has added four liver cell types to its hepatocytes portfolio for testing of in vitro drug models.
May 30, 2018
By Pharmaceutical Technology Editors
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
May 30, 2018
By Pharmaceutical Technology Editors
The new draft guidance addresses the premarketing assessment of a drug’s effect on blood pressure.
May 23, 2018
By Pharmaceutical Technology Editors
The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
May 23, 2018
By Pharmaceutical Technology Editors
Allergan will buy a potential depression treatment from Aptinyx.
May 23, 2018
The combination of translatable in-vitro and in-vivo assays, coupled with expertise in immunology and oncology helps facilitate the progression of novel oncology therapeutics from hit identification to investigational new drug submission.
May 17, 2018
By Pharmaceutical Technology Editors
The FDA commissioner released a statement expressing the agency’s plan to address tactics used by pharma companies to delay generic-drug competition.
May 16, 2018
By Pharmaceutical Technology Editors
ExcipientFest has been acquired by IPEC and rebranded as Excipient World.
May 16, 2018
By Pharmaceutical Technology Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 15, 2018
Pharmaceutical Technology
Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
native1_300x100
lorem ipsum